Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.79 - $1.91 $42,331 - $102,345
-53,584 Reduced 51.24%
50,998 $41,000
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $15,171 - $26,900
10,760 Added 11.47%
104,582 $163,000
Q3 2022

Nov 14, 2022

SELL
$1.66 - $2.79 $118,243 - $198,734
-71,231 Reduced 43.16%
93,822 $162,000
Q2 2022

Aug 22, 2022

BUY
$1.44 - $3.98 $6,212 - $17,169
4,314 Added 2.68%
165,053 $286,000
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $292,564 - $395,943
40,861 Added 34.09%
160,739 $1.15 Million
Q2 2021

Aug 12, 2021

SELL
$6.23 - $10.03 $28,489 - $45,867
-4,573 Reduced 3.67%
119,878 $1.11 Million
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $246,160 - $473,879
27,941 Added 28.95%
124,451 $1.15 Million
Q4 2020

Feb 12, 2021

SELL
$8.5 - $12.85 $1,513 - $2,287
-178 Reduced 0.18%
96,510 $854,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $27.05 $506,253 - $1.43 Million
52,900 Added 120.81%
96,688 $1.12 Million
Q2 2020

Aug 14, 2020

BUY
$7.14 - $31.69 $159,529 - $708,049
22,343 Added 104.19%
43,788 $1.18 Million
Q1 2020

May 14, 2020

SELL
$2.98 - $14.09 $14,661 - $69,322
-4,920 Reduced 18.66%
21,445 $159,000
Q4 2019

Feb 13, 2020

BUY
$1.97 - $3.72 $1,883 - $3,556
956 Added 3.76%
26,365 $87,000
Q3 2019

Nov 13, 2019

BUY
$2.05 - $3.02 $12,240 - $18,032
5,971 Added 30.72%
25,409 $52,000
Q2 2019

Aug 14, 2019

BUY
$2.29 - $4.1 $7,270 - $13,017
3,175 Added 19.52%
19,438 $57,000
Q1 2019

May 15, 2019

BUY
$3.34 - $5.1 $3,443 - $5,258
1,031 Added 6.77%
16,263 $60,000
Q4 2018

Feb 15, 2019

BUY
$3.89 - $6.11 $9,160 - $14,389
2,355 Added 18.29%
15,232 $61,000
Q2 2018

Aug 10, 2018

SELL
$3.88 - $5.16 $7,519 - $10,000
-1,938 Reduced 13.08%
12,877 $51,000
Q1 2018

May 17, 2018

SELL
$4.05 - $5.69 $24,721 - $34,731
-6,104 Reduced 29.18%
14,815 $70,000
Q4 2017

Feb 13, 2018

BUY
$4.13 - $6.68 $86,395 - $139,738
20,919
20,919 $86,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.